Animal skin morphology and dermal absorption

Dermal Absorption and Toxicity Assessment, Second Edition

Volumn , Issue , 2007, Pages 17-36

  Monteiro Riviere, Nancy A ^a   Baynes, Ronald E ^a   Riviere, Jim E ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952889776     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (52)

1. Monteiro-Riviere NA. Comparative anatomy, physiology, and biochemistry of mammalian skin. In:Hobson DW, ed. Dermal and Ocular Toxicology: Fundamentals and Methods. New York: CRC Press Inc., 1991;3-71.
2. Monteiro-Riviere NA. The integument. In:Eurell J, Frappier B, eds. Dellmann’s Textbook of Veterinary Histology. Ames, Iowa: Blackwell Publishing, 2006;320-49.
3. Monteiro-Riviere NA, Bristol DG, Manning TO, et al. Interspecies and inter-regional analysis of the comparative histological thickness and laser doppler blood flow measurements at five cutaneous sites in nine species. J Invest Dermatol 1990; 95:582-6.
4. Halprin KM. Epidermal “turnover time” a reexamination. Br J Dermatol 1972; 86:14-9.
5. Bergstresser PR, Taylor JR. Epidermal “turnover time” a new examination. Br J Dermatol 1977; 96:503-9.
6. Weinstein GD. Comparison turnover time of keratinous protein fractions in swine and human epidermis. In:Bustad LK, McClellan RO, Burns MP, eds. Swine in Biomedical Research. Richland, WA: Pacific Northwest Laboratory, 1966;287-97.
7. Monteiro-Riviere NA, Inman AO, Mak V, et al. Effect of selective lipid extraction from different body regions on epidermal barrier function. Pharm Res 2001; 18:992-8.
8. Monteiro-Riviere NA, Inman AO. Indirect immunohistochemistry and immunoelectron microscopy distribution of eight epidermal-dermal junction epitopes in the pig and in isolated perfused skin treated with bis (2-chloroethyl) sulfide. Toxicol Pathol 1995; 23:313-25.
9. Zhang Z, Monteiro-Riviere NA. Comparison of integrins in human skin, pig skin, and perfused skin: an in vitro skin toxicology model. J Appl Toxicol 1997; 17:247-53.
10. Grissom RE, Monteiro-Riviere NA, Guthrie FE. A method for preparing mouse skin for assessing in vitro dermal penetration of xenobiotics. Toxicol Lett 1987; 36:251-8.
11. Monteiro-Riviere NA. The integument. In:Pond WG, Mersmann HJ, eds. The Biology of the Domestic Pig. Ithaca, NY: Cornell University Press, 2001;625-52.
12. Stewart ME. Sebaceous gland lipids. Semin Dermatol 1992; 11:100-5.
13. Argenzio RA, Monteiro-Riviere NA. The excretory system. In:Pond WG, Mersmann HJ, eds. The Biology of the Domestic Pig. Ithaca, NY: Cornell University Press, 2001;585-624.
14. Crow KD, Puhvel M. Chloracne. In:Marzulli FN, Maibach HI, eds. Dermatotoxicology. 3rd ed. Washington: Hemisphere Publishing, 1977;515-34.
15. Bijman J. Transport processes in the eccrine sweat gland. Kidney Int 1987; 32:S109-12.
16. K conductance and acid secretion in the human sweat duct. Ann NY Acad Sci 1989; 574:438-46.
17. Ebling FJG. Aprocine glands in health and disorder. Int J Dermatol 1989; 28:508-11.
18. Elias PM. Epidermal lipids, barrier function, and desquamation. J Invest Dermatol 1983; 80:44-9.
19. Riviere JE, Papich M. Potential and problems of developing transdermal patches for veterinary applications. Adv Drug Deliv Rev 2001; 50:175-203.
20. Monteiro-Riviere NA. Anatomical factors affecting barrier function. In:Marzulli FN, Maibach HI, eds. Dermatotoxicology. 5th ed. Washington: Taylor & Francis, 1996;3-17.
21. Bartek MJ, LaBudde JL, Maibach HI. Skin permeability in vivo: comparison in rat, rabbit, pig and man. J Invest Dermatol 1972; 58:114-23.
22. Hawkins GS, Reifenrath WG. Development of an in vitro model for determining the fate of chemicals applied to the skin. Fundam Appl Toxicol 1984; 4:S133-44.
23. Riviere JE, Monteiro-Riviere NA. The isolated perfused porcine skin flap as an in vitro model for percutaneous absorption and cutaneous toxicology. CRC Crit Rev Toxicol 1991; 21:329-44.
24. Wester RC, Maibach HI. Animal models for percutaneous absorption. In:Wang RGM, Knaak JB, Maibach HI, eds. Health Risk Assessment: Dermal and Inhalation Exposure and Absorption of Toxicants. Boca Raton, FL: CRC Press, 1993;89-104.
25. Riviere JE, Monteiro-Riviere NA, Williams PL. Isolated perfused porcine skin flap as an in vitro model for predicting transdermal pharmacokinetics. Eur J Pharm Biopharm 1995; 41:152-62.
26. Baynes RE, Halling KB, Riviere JE. The influence of diethyl-m-toluamide (DEET) on the percutaneous absorption of permethrin and carbaryl. Toxicol Appl Pharmacol 1997; 144:332-9.
27. Srikrishna V, Riviere JE, Monteiro-Riviere NA. Cutaneous toxicity and absorption of paraquat in porcine skin. Toxicol Appl Pharmacol 1992; 115:89-97.
28. Walker M, Dugard PH, Scott RC. In vitro percutaneous absorption studies: a comparison of human and laboratory species. Hum Toxicol 1983; 2:561-8.
29. Wester RC, Maibach HI, Bucks DA, et al. In vivo percutaneous absorption of paraquat from hand, leg, and forearm of humans. J Toxicol Environ Health 1984; 14:759-62.
30. Chui YC, Poon G, Law F. Toxicokinetics and bioavailability of paraquat in rats following different routes of administration. Toxicol Ind Health 1988; 4:203-19.
31. Sato K, Sugibayashi K, Morimoto Y. Species differences in percutaneous absorption of nicorandil. J Pharm Sci 1991; 80:104-7.
32. 14C] permethrin. Toxicol Appl Pharmacol 2002; 181:164-73.
33. Franz TJ, Lehman PA, Franz SF, et al. Comparative percutaneous absorption of lindane and permethrin. Arch Dermatol 1996; 132:901-5.
34. Wester RC, Melendres J, Sedik L, et al. Percutaneous absorption of salicylic acid, theophylline, 2,4-dimethylamine, diethyl hexyl phthalic acid, and p-aminobenzoic acid in the isolated perfused porcine skin flap compared to man in vivo. Toxicol Appl Pharmacol 1998; 151:159-65.
35. Dick IP, Scott RC. Pig ear skin as an in-vitro model for human skin permeability. J Pharm Pharmacol 1992; 44:640-5.
36. Bartek MJ, LaBudde JA. Percutaneous absorption in vitro. In:Maibach HI, ed. Animal Models in Dermatology. New York: Churchill-Livingstone, 1975;103-20.
37. Feldmann RJ, Maibach HI. Percutaneous penetration of some pesticides and herbicides in man. Toxicol Appl Pharmacol 1974; 28:126-32.
38. Grond S, Radbruch L, Lehmann KA. Clinical pharmacokinetics of transdermal opioids:focus on transdermal fentanyl. Clin Pharmacokinet 2000; 38:59-89.
39. Hofmeister EH, Egger CM. Transdermal fentanyl patches in small animals. J Am Anim Hosp Assoc 2004; 40:468-78.
40. Kyles AE, Papich M, Hardie EM. Disposition of transdermally administered fentanyl in dogs. Am J Vet Res 1996; 57:715-9.
41. Varvel JR, Shafer SL, Hwang SS, et al. Absorption characteristics of transdermally administered fentanyl. Anesthesiology 1989; 70:928-34.
42. Lee DD, Papich MG, Hardie EM. Comparison of pharmacokinetics of fentanyl after intravenous and transdermal administration in cats. Am J Vet Res 2000; 61:672-7.
43. Roy SD, Hou SL, Withman SL, et al. Transdermal delivery of narcotic analgesics:comparative metabolism and permeability of human cadaver skin and hairless mouse skin. J Pharm Sci 1994; 83:1723-8.
44. Hoffman SB, Yoder AR, Trepanier LA. Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats. J Vet Pharmacol Ther 2002; 25:189-93.
45. Bennett N, Papich MG, Hoenig M, et al. Evaluation of transdermal application of glipizide in a pluronic lecithin gel to healthy cats. Am J Vet Res 2005; 66:581-8.
46. Lécuyer M, Prini S, Dunn M, et al. Clinical efficacy and safety of transdermal methimazole in the treatment of feline hyperthyroidism. Can Vet J 2006; 47:131-5.
47. Sarasola P, Jernigan AD, Walker DK, et al. Pharmacokinetics of selamectin following intravenous, oral and topical administration in cats and dogs. Vet Pharmacol Ther 2002; 25:265-72.
48. Alvinerie M, Lacoste E, Sutra JF, et al. Some pharmacokinetic parameters of eprinomectin in goats following pour-on administration. Vet Res Commun 1999; 23:449-55.
49. Alvinerie M, Sutra JF, Galtier P, et al. Pharmacokinetics of eprinomectin in plasma and milk following topical administration to lactating dairy cattle. Res Vet Sci 1999; 67:229-32.
50. Chartier C, Etter E, Pors I, et al. Activity of eprinomectin in goats against experimental infections with Haemonchus contortus, Teladorsagia circumcincta and Trichostrongylus colubriformis. Vet Rec 1999; 144:99-100.
51. Baynes RE. In vitro dermal disposition of abamectin (avermectin B1) in livestock. Res Vet Sci 2004; 76:235-42.
52. Wislocki PG, Feely WF, White S, et al. Dermal penetration of avermectin B1a in the rhesus monkey. Toxicol Appl Pharmacol 1988; 94:238-45.